NABI Biomedical Center

Nabi Biopharmaceuticals is focused on developing products that address unmet medical requirements and provide opportunities in our main business areas: nicotine addiction and gram-positive bacterial infections. Driven by our clinical development programs, we're focused on building value for our vaccine programs: NicVAX (Nicotine Conjugate Vaccine) and EnteroVAX (Enterococcus faecalis Conjugate Vaccine) Our headquarters is situated in Rockville, Maryland along with our Research and Development facility.